Unicycive
  • Company
  • Therapeutic Focus
  • Pipeline
    • UNI-494
    • Renazorb
  • Investors
  • Contact

News

Investors

Investors

  • Overview
  • News
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial & Stock Info
    • Overview
    • Financial Results
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Resources
    • Overview
    • Contacts
    • FAQ
    • Email Alerts
Feb 02, 2023 8:30am EST

Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea

Jan 23, 2023 7:00am EST

Unicycive Announces Acceptance of Three Abstracts for Presentation at the National Kidney Foundation’s Spring Clinical Meetings

Jan 05, 2023 7:00am EST

Unicycive Announces Acceptance of Four Abstracts for Presentation at the World Congress of Nephrology 2023

Dec 29, 2022 11:31am EST

Unicycive Announces Termination of “At-The-Market” Offering of Shares of Common Stock

Dec 28, 2022 8:30am EST

Unicycive Achieves Primary Endpoint in Pivotal Bioequivalence Study of Renazorb

Dec 22, 2022 7:00am EST

Unicycive Issued Notice of Acceptance to Initiate Phase 1 Study of UNI-494 Following Review of Clinical Trial Application by the Medicines and Healthcare Products Regulatory Agency in the United Kingdom

Nov 28, 2022 7:00am EST

Unicycive to Participate in Upcoming Investor Conferences

Nov 21, 2022 7:00am EST

Unicycive Reports Key Findings of UNI-494 Efficacy in Preclinical Animal Model of Geographic Atrophy

Nov 14, 2022 7:00am EST

Unicycive Announces Third Quarter Financial Results and Provides Business Update

Nov 10, 2022 7:00am EST

Unicycive Completes Enrollment of Pivotal Bioequivalence Study for RENAZORB™ (lanthanum dioxycarbonate), an Investigational Treatment for Hyperphosphatemia in Chronic Kidney Disease (CKD) Patients on Dialysis

  • 1
  • 2
  • 3
  • 4
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Legal Notices and Terms of Use
Privacy Policy
Ad and Cookie Policy
Contact Us >

Copyright © 2023 Unicycive

  • Twitter
  • LinkedIn